Pharmacokinetically guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients
Publication year
2022Source
British Journal of Clinical Pharmacology, 88, 8, (2022), pp. 3920-3921ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Clinical Pharmacy
Pulmonary Diseases
Journal title
British Journal of Clinical Pharmacology
Volume
vol. 88
Issue
iss. 8
Page start
p. 3920
Page end
p. 3921
Subject
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [226905]
- Faculty of Medical Sciences [86456]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.